Biotech Firm Develops Cancer Antibody Wealth Daily The agreement will see Genmab grant Janssen an exclusive global license to develop and market both daratumumab and a backup human CD38 antibody. From the Sacramento Bee: "Janssen was one of the first companies to recognize the power and ... The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis ... |
Tuesday, September 4, 2012
Biotech Firm Develops Cancer Antibody - Wealth Daily
idozxun.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment